AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting riskEarnings are out

SLQT · NYSE · Insurance - Brokers

SelectQuote

Connects consumers with Medicare, life insurance, pharmacy and healthcare services.

$0.5202

After-hours close−0.00 (−0.36%)

At close$0.5221(−3.31%)

Something off on this page? Send us feedback.

Profile

SelectQuote, Inc.SLQTFinancials

Distributes Medicare and life insurance while providing SelectRx pharmacy and healthcare engagement services. Licensed agents and proprietary technology support a direct-to-consumer model focused on senior customers.

Licensed agents and proprietary technology connect consumers with insurance and health-related services through three lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. Senior focuses on Medicare-plan distribution, while Life distributes life insurance.

Healthcare Services includes SelectRx pharmacy, SelectPatient Management, and Healthcare Select, extending the senior-customer relationship into medication management and health engagement. The U.S.-focused direct-to-consumer business serves consumers and depends on consultative needs analyses by licensed agents and technology that sources and routes leads. A DOJ complaint disclosed by the company alleges False Claims Act violations; the allegations are not findings.

Company facts

CEOTimothy "Tim" Danker

ListedMay 21, 2020

ExchangeNYSE

HeadquartersOverland Park, KS

CountryUnited States

Employees4,269

CIK0001794783

ISINUS8163073005

Key statistics

Market cap$91.7M

EPS (ttm)−$0.0700

P/E (ttm)−7.43

ROE10.0%

P/B0.1519

P/S0.0567

Dividend yield—

Beta2.67vs XLF 0.52

Year to date −61.9% · Average volume (30d) 1.1M

Analysts

Price target, next 12 months$3.00+476.9%Median of 11 analysts · vs the Aug 28 close

ConsensusHold4 of 11 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $0.5200

High$5.00+861.5%

Median$3.00+476.9%

Low$1.50+188.5%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
Feb 6, 2026	Craig-Hallum	Target			$3
Nov 20, 2025	RBC Capital	Reiterate	Sector Perform	$2	$5

Earnings

EPS

Estimate−$0.26

ReportedDue Nov 5, 2026

Revenue

Estimate$277.9M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 25, 2026Q4 FY26	−$0.17	−$0.19	−15.2%	$353.4M	$321.7M	−9.0%	−29.34%
May 5, 2026Q3 FY26	−$0.02	$0.15	+850.0%	$438.9M	$430.9M	−1.8%	−3.23%
Feb 5, 2026Q2 FY26	$0.17	$0.26	+52.9%	$530.7M	$537.1M	+1.2%	+6.80%
Nov 6, 2025Q1 FY26	−$0.32	−$0.26	+18.8%	$323.7M	$328.8M	+1.6%	+2.98%

View details

Financial highlights

	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	$408.2M	$345.1M	$328.8M	$537.1M	$430.9M	$321.7M
Gross profit	$166.4M	$103.9M	$66.9M	$626.8M	$176.1M	$436.5M
Operating income	$22.1M	−$12.5M	−$40.7M	$75.3M	$36.6M	$4.9M
Net income	$26.0M	$12.9M	−$30.5M	$69.3M	$40.2M	−$16.8M
Diluted EPS	$0.12	−$0.02	−$0.26	$0.27	$0.11	−$0.19
Gross margin	40.8%	30.1%	20.4%	116.7%	40.9%	135.7%
Operating margin	5.4%	-3.6%	-12.4%	14.0%	8.5%	1.5%

Fiscal years (4-quarter sums)FY22 $761.1M · FY23 $1.00B · FY24 $1.32B · FY25 $1.53B · FY26 $1.62B

Revenue by product · Q4 FY26

Pharmacy$189.8M · 59%

Service$131.8M · 41%

Balance sheet, Jun 30, 2026Cash & short-term investments $20.7M · Total debt $48.2M · Total assets $1.52B · Shareholders' equity $650.0M

Dividends

No dividends on record.

Ownership

Institutions 40.10%70.71M sharesInsiders 7.56%13.34M sharesOther 52.34%92.30M shares

Shares outstanding 176.35M · Float 141.93M · 80.5% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	10.71M	6.08%	13F	May 13, 2026
Abrams Bison Investments, LLC	7.91M	4.49%	13F	May 15, 2026
Mariner, LLC	6.49M	3.68%	13F	May 13, 2026
Vanguard Capital Management LLC	5.99M	3.40%	13F	May 15, 2026
Geode Capital Management, LLC	3.48M	1.98%	13F	May 15, 2026

Insider tradesForm 4

Date	Insider	Role	Shares	Avg price
May 19, 2026	Denise L. Devine	director	−4,000	$1.02
Feb 11, 2026	Robert Clay Grant	officer: PRESIDENT	+118,901	$0.8833